BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19479954)

  • 1. A novel mutation in CD40 and its functional characterization.
    Qi CJ; Zheng L; Ma HB; Fei M; Qian KQ; Shen BR; Wu CP; Vihinen M; Zhang XG
    Hum Mutat; 2009 Jun; 30(6):985-94. PubMed ID: 19479954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
    Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
    Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40/CD40L interaction induces Abeta production and increases gamma-secretase activity independently of tumor necrosis factor receptor associated factor (TRAF) signaling.
    Volmar CH; Ait-Ghezala G; Frieling J; Weeks OI; Mullan MJ
    Exp Cell Res; 2009 Aug; 315(13):2265-74. PubMed ID: 19422822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and analysis of a detailed three-dimensional model of the ligand binding domain of the human B cell receptor CD40.
    Bajorath J; Aruffo A
    Proteins; 1997 Jan; 27(1):59-70. PubMed ID: 9037712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperativity in the interaction of synthetic CD40L mimetics with CD40 and its implication in cell signaling.
    Wieckowski S; Trouche N; Chaloin O; Guichard G; Fournel S; Hoebeke J
    Biochemistry; 2007 Mar; 46(11):3482-93. PubMed ID: 17319699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of polar interactions in the molecular recognition of CD40L with its receptor CD40.
    Singh J; Garber E; Van Vlijmen H; Karpusas M; Hsu YM; Zheng Z; Naismith JH; Thomas D
    Protein Sci; 1998 May; 7(5):1124-35. PubMed ID: 9605317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD154-CD40 interactions are essential for thymus-dependent antibody production in zebrafish: insights into the origin of costimulatory pathway in helper T cell-regulated adaptive immunity in early vertebrates.
    Gong YF; Xiang LX; Shao JZ
    J Immunol; 2009 Jun; 182(12):7749-62. PubMed ID: 19494299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAF2 and p38 are involved in B cells CD40-mediated APE/Ref-1 nuclear translocation: a novel pathway in B cell activation.
    Merluzzi S; D'Orlando O; Leonardi A; Vitale G; Pucillo C
    Mol Immunol; 2008 Jan; 45(1):76-86. PubMed ID: 17599408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
    Ruybal P; Gravisaco MJ; Barcala V; Escalada A; Di Sciullo P; Waldner C; Mongini C
    Vaccine; 2008 Jan; 26(5):697-705. PubMed ID: 18155328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linking of CD40 using anti-CD40 antibody, 5C11, has different effects on XG2 multiple myeloma cells.
    Qi CJ; Zheng L; Zhou X; Tao Y; Ge Y; Zhuang YM; Xu Y; Yu G; Zhang XG
    Immunol Lett; 2004 May; 93(2-3):151-8. PubMed ID: 15158611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organic dyes as small molecule protein-protein interaction inhibitors for the CD40-CD154 costimulatory interaction.
    Buchwald P; Margolles-Clark E; Kenyon NS; Ricordi C
    J Mol Recognit; 2010; 23(1):65-73. PubMed ID: 19621420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of carbohydrate structures N-linked to soluble CD154 and characterization of the interactions of CD40 with CD154 expressed in Pichia pastoris and Chinese hamster ovary cells.
    Khandekar SS; Silverman C; Wells-Marani J; Bacon AM; Birrell H; Brigham-Burke M; DeMarini DJ; Jonak ZL; Camilleri P; Fishman-Lobell J
    Protein Expr Purif; 2001 Nov; 23(2):301-10. PubMed ID: 11676606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of CD154 by Kaposi's sarcoma cells mediates the anti-apoptotic and migratory effects of HIV-1-TAT protein.
    Cantaluppi V; Deregibus MC; Biancone L; Deambrosis I; Bussolati B; Albini A; Camussi G
    Int J Immunopathol Pharmacol; 2006; 19(1):81-96. PubMed ID: 16569346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse CD40-transfected cell lines cannot exhibit the binding and RANTES-stimulating activity of exogenous heat shock protein 70.
    Tao Y; Nomura M; Kitabatake N; Tani F
    Mol Immunol; 2007 Feb; 44(6):1262-73. PubMed ID: 16930707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outside inside signalling in CD40-mediated B cell activation.
    D'Orlando O; Gri G; Cattaruzzi G; Merluzzi S; Betto E; Gattei V; Pucillo C
    J Biol Regul Homeost Agents; 2007; 21(3-4):49-62. PubMed ID: 18261257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD40 and growth-inhibitory activity of CD40 ligand in colon cancer ex vivo.
    Wu Y; Wang L; He X; Xu H; Zhou L; Zhao F; Zhang Y
    Cell Immunol; 2008; 253(1-2):102-9. PubMed ID: 18603231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of binding activity of soluble human CD40 to CD40 ligand through incorporation of an isoleucine zipper motif.
    He XH; Xu LH; Liu Y
    Acta Pharmacol Sin; 2006 Mar; 27(3):333-8. PubMed ID: 16490170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular HSP70 blocks CD40L-induced apoptosis and tubular formation in endothelial cells.
    Futagami S; Hiratsuka T; Shindo T; Hamamoto T; Horie A; Ueki N; Kusunoki M; Gudis K; Miyake K; Tsukui T; Sakamoto C
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S222-8. PubMed ID: 19120902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features.
    Lougaris V; Badolato R; Ferrari S; Plebani A
    Immunol Rev; 2005 Feb; 203():48-66. PubMed ID: 15661021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40 and vascular inflammation.
    Urbich C; Dimmeler S
    Can J Cardiol; 2004 May; 20(7):681-3. PubMed ID: 15197419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.